Here we are at the midpoint of 2006 already. The first half stock market doesn't look pretty! The Dow is up a modest 4%. Two months ago, the Dow was up twice that level but took a tumble in May falling sharply in June and beginning to bounce back in July. The NASDAQ has really taken a hit in these first 6 months, having dropped 2%.
We all know about continue......Full article >>>
$2.7 billion. Imagine what will happen with Pfizer's Lipitor with last year's sales of $13 billion (granted this is worldwide and Pfizer's patent expiration in different parts of the world varies).
More recently, during the last 3 years, Big Pharma has experimented with a different formula called "authorized generics". Under this scenario, in advance of patent expiration, Big Pharma has ......Full article >>>
, and the completion of the Boston Scientific/Abbott Lab's acquisition of Guidant (with Abbott acquiring an equity chunk of Boston Scientific in the process). Of note, in the last week was the disposal by Pfizer of its consumer products business to J&J for over $7 billion. This includes products like Listerine and other products Pfizer had obtained in the Warner-Lambert acquisition along with Pfiz......Full article >>>
|7. Merck (MRK)||$36.43||$31.99||+14%||$ 79.5|
|8. Abbott Labs (ABT)||$43.61||$46.50||<4%>||$ 66.6|
|9. Eli Lilly (LLY)||$55.27||$56.77||<3%>||$ 62.5|
|10. Wyeth (WYE)||$44.4......|
Full article >>>
han the NASDAQ and AMEX Biotech indices. Not a pretty first half!
Big biotech stock performance 2006
|Biotech Company/Ticker||Stock Price June 30, 2006||Stock Price Jan.2, 2006||%Change||Market Cap(S B)|
|NASDAQ Biotech Index||742.87||795.32......|
Full article >>>
period and shut for 1-2 years. The current IPO window has lingered open since the 4th quarter of 2004; however it has not been a strong market, with low initial pricings and valuations. Nevertheless, it continues to remain open! We will look at this further in weeks to come!
One issue that both Big Pharma and biotech companies face: increasing resistance to high pricing on new ......
Full article >>>
Source:wistechnology.com By Michael Rosen 07/03/06
Related biology technology :
1. The Genesis of Gendicine: The Story Behind the First Gene Therapy
2. Business Objects to acquire La Crosse-based Firstlogic
3. Pitney Bowes and Firstlogic cancel acquisition plans
4. Tech Digest: Fiserv, IMS, Honeywell HomMed, Firstlogic
5. Tech Digest: Firstlogic, Fiserv, Red Prairie, Spectrum Brands, Associated Bank
6. J.J. Keller, Modine Manufacturing, Gustave A. Larson Co., Esker, Firstlogic, Software One
7. Pitney Bowes to acquire Firstlogic
8. Firstlogic, Informatica expand OEM partnership
9. Crate and Barrel deploys Firstlogics Information Quality Suite
10. Merkle selects Firstlogic data quality software
11. First pieces of Antarctic deep-space particle detector are in place
(Date:6/23/2016)... 23, 2016 EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ... Breaking Biology Technology:
(Date:4/13/2016)... April 13, 2016 IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ... Breaking Biology News(10 mins):